Previously used against seasonal influenza, SARS, and pandemic swine flu, it was added to China's standard of care for COVID-19 in April 2020. Is this one of the reasons their death rate is so low, and why are most Western governments ignoring it?
Sweet Wormwood Again Shows Effectiveness Against COVID-19
Sweet wormwood (Artemisia annua) is a traditional plant-based medicine with antiparasitic, antiviral and anticancer properties. Studies show it’s also an effective remedy in the treatment of mild to moderate COVID-19
In April 2020, China added three Traditional Chinese Medicine (TCM) formulas to its standard of care for COVID-19, including one containing sweet wormwood, called Jinhua Qinggan
In one COVID-specific study, Jinhua Qinggan granules were found to significantly alleviate fever, cough, fatigue, sputum, anxiety and need for hospitalization. Most recently, a Pakistani trial found the TCM remedy was 82.6% effective when used in COVID-positive patients treated at home for mild to moderate infection
In February 2022, Saudi Arabian researchers published a paper detailing how one of its main components, artemisinin, and its derivatives inhibit SARS-CoV-2 infection by binding to an enzyme the virus uses to multiply within the cell and disarm the host’s immune defenses
Artemisia annua is also bioactive against other viruses, including cytomegalovirus, hepatitis B and C, and members of the herpes family, including herpes virus type 1 and Epstein-Barr